Gras-Champel V - Search Results

1

Adverse Drug Reactions in Patients with CKD.

Laville SM, Gras-Champel V, Moragny J, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Stengel B, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Laville SM, et al. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1090-1102. doi: 10.2215/CJN.01030120. Epub 2020 Jul 1. Clin J Am Soc Nephrol. 2020. PMID: 32611662 Free PMC article.

2

[Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].

Roskiewicz F, Andriamanana I, Gras-Champel V, Andrejak M, Massy ZA. Roskiewicz F, et al. Nephrol Ther. 2007 Jun;3(3):89-95. doi: 10.1016/j.nephro.2007.03.003. Epub 2007 Apr 18. Nephrol Ther. 2007. PMID: 17540310 Review. French.

3

Lemaire-Hurtel AS, Gras-Champel V, Hary L, Masmoudi K, Massy Z, Andréjak M. Lemaire-Hurtel AS, et al. Nephrol Ther. 2009 Apr;5(2):144-8. doi: 10.1016/j.nephro.2008.10.004. Epub 2008 Dec 13. Nephrol Ther. 2009. PMID: 19071080 French.

4

[Quantification of the part allocated to the preventability of vitamin K antagonists therapy bleeding events].

Gras-Champel V, Brenet-Dufour V, Moragny J, Masson H, Davidau E, Masmoudi K, Andrejak M. Gras-Champel V, et al. Therapie. 2010 May-Jun;65(3):261-8. doi: 10.2515/therapie/2010010. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699080 French.

5

Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists.

Liabeuf S, Scaltieux LM, Masmoudi K, Roussel B, Moragny J, Andrejak M, Gras-Champel V. Liabeuf S, et al. Medicine (Baltimore). 2015 Dec;94(52):e2366. doi: 10.1097/MD.0000000000002366. Medicine (Baltimore). 2015. PMID: 26717378 Free PMC article.

6

Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists.

Liabeuf S, Masmoudi K, Scailteux LM, Moragny J, Masson H, Brnet-Dufour V, Andrejak M, Gras-Champel V. Liabeuf S, et al. Medicine (Baltimore). 2016 Sep;95(39):e4762. doi: 10.1097/MD.0000000000004762. Medicine (Baltimore). 2016. PMID: 27684801 Free PMC article.

7

Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.

Gras-Champel V, Batteux B, Masmoudi K, Liabeuf S. Gras-Champel V, et al. Muscle Nerve. 2019 Oct;60(4):382-386. doi: 10.1002/mus.26637. Epub 2019 Jul 29. Muscle Nerve. 2019. PMID: 31298743

8

Statin-associated myasthenia: A case report and literature review.

Gras-Champel V, Masmoudi I, Batteux B, Merle PE, Liabeuf S, Masmoudi K. Gras-Champel V, et al. Therapie. 2020 May-Jun;75(3):301-309. doi: 10.1016/j.therap.2019.07.004. Epub 2019 Jul 26. Therapie. 2020. PMID: 31477339 Review. No abstract available.

9

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study.

Rey A, Batteux B, Laville SM, Marienne J, Masmoudi K, Gras-Champel V, Liabeuf S. Rey A, et al. Arthritis Res Ther. 2019 Nov 8;21(1):229. doi: 10.1186/s13075-019-2011-y. Arthritis Res Ther. 2019. PMID: 31703711 Free PMC article.

10

[Evaluation and impact of "pregnancy" pharmaceutical pictograms among 281 women].

Bertrand D, Piedeloup I, Mattoug S, Liabeuf S, Gras-Champel V. Bertrand D, et al. Therapie. 2020 Sep-Oct;75(5):449-458. doi: 10.1016/j.therap.2019.11.001. Epub 2019 Nov 25. Therapie. 2020. PMID: 31831186 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page